FDA Adverse Event Injury Summary report: N

GMK SPHERE TOTAL KNEE SYSTEM

MDR report key: 23615347 · Received November 21, 2025

Report

Report Number
3005180920-2025-01170
Event Type
Injury
Date Received
November 21, 2025
Date of Event
November 4, 2025
Report Date
November 21, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630971261457
PMA / PMN Number
K202022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 10 NOVEMBER 2025. GMK-SPHERIKA 02.12.E0217FL GMK-SPHERE TIBIAL INSERT E-CROSS - FLEX 2L (K202022) LOT 2338896: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 11-OCT-2023. EXPIRATION DATE: 25-SEP-2028. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. GMK-SPHERIKA 02.12.KA12L GMK SPHERIKA FEMORAL COMPONENT S2+L CEMENTED (K211004) LOT 2424064: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 20-NOV-2024. EXPIRATION DATE: 04-NOV-2029. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ROOT CAUSE: BASED ON THE INFORMATION AVAILABLE NO DEFINITIVE ROOT CAUSE CAN BE ESTABLISHED, WHILE THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT, AND THE DEVICE HISTORY RECORD REVIEW DOES NOT INDICATE ANY POTENTIAL MANUFACTURING RELATED ISSUE.

Description of Event or Problem · 0

AT ABOUT 3 MOUNTHS FROM THE PRIMARY, THE PATIENT CAME IN REPORTING INSTABILITY AND THE CAUSE IS UNKNOWN. THE SURGEON UPSIZED THE LINER (FROM 17 MM TO 20 MM) TO GIVE THE PATIENT MORE STABILITY AND REVISED THE FEMUR. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2076217 GMK SPHERE TOTAL KNEE SYSTEM GMK-SPHERE TIBIAL INSERT E-CROSS - FLEX 2L - 17MM JWH MEDACTA INTERNATIONAL SA 02.12.E0217FL 2338896 07630971261457

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention